Borregaard's operating revenues increased to NOK 1,833 million (NOK 1,744 million)2 in the 4th quarter of 2025. EBITDA1 was NOK 405 million (NOK 398 million). The result in BioMaterials increased, while BioSolutions and Fine Chemicals had lower results compared with the 4th quarter of 2024.
In BioSolutions, high deliveries of biovanillin and sustained growth in sales to agriculture were more than offset by increased costs. For BioMaterials, higher sales prices and lower wood and energy costs, more than compensated for other cost increases. For Fine Chemicals, lower bioethanol sales prices were partly offset by a strong result for fine chemical intermediates. Net currency effects were slightly positive for the Group.
In the 4th quarter of 2025, Borregaard has made a total impairment of NOK 245 million of its investments in the bio-based start-ups Alginor ASA, Kaffe Bueno ApS and Lignovations GmbH to reflect recent development in these companies. The impairment is recorded as part of financial items.
Profit before tax was NOK -28 million (NOK 170 million). Earnings per share were NOK -0.81 (NOK 1.30). Excluding impairments of bio-based start-ups, earnings per share were NOK 1.64.
Full year 2025
Operating revenues increased to NOK 7,713 million (NOK 7,617 million) in 2025. EBITDA1 was NOK 1,878 million (NOK 1,874 million), an all-time high result. BioSolutions and BioMaterials had improved results, while Fine Chemicals had a decrease compared with 2024. Profit before tax was NOK 864 million (NOK 1,079 million). Earnings per share were NOK 6.22 (NOK 8.25). Excluding impairments of bio-based start-ups, earnings per share were NOK 8.67.
- We are pleased to report another all- time high EBITDA1 in 2025, driven by strong momentum across our business segments, despite the sharp decline in bioethanol prices and higher costs, says CEO Tom Erik Foss-Jacobsen.
Contacts:
Director Investor Relations, Pål Espen Ramberg, +47 959 17 333
Director Communications, Tone Horvei Bredal, +47 924 67 711
1. Operating profit before depreciation, amortisation and other income and expenses
2. Figures in parentheses are for the corresponding period in the preceding year
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5 - 12 of the Norwegian Securities Trading Act.
This stock exchange announcement was published by Lotte Kvinlaug, Investor Relations Officer at Borregaard ASA, on 4 February 2026 at 07:00 CET.
